BioCatalyst

Glofitamab, Atezolizumab, Obinutuzumab, Tocilizumab — catalyst calendar

1 verified catalyst event(s) referencing Glofitamab, Atezolizumab, Obinutuzumab, Tocilizumab, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-16
in 2mo
ESTIMATED
 READOUT
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Ve
Phase 1/2 · Non-Hodgkins Lymphoma
 Hoffmann-La Roche Glofitamab, Atezolizumab, Obinutuzumab, ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.